does insurance cover glp-1 medications Medicaid Drugs? A State-by-State Guide — StateVitals Medicaid Coverage of and Spending

[DOI] [PMC free article] [PubMed] [Google Scholar] 715.Fay R.R

Seven drugs have currently been approved for the treatment of Type 2 diabetes mellitus, including short-acting agents like exenatide and lixisenatide, as well as long-acting injectable agents such as albiglutide, dulaglutide, liraglutide, and semaglutide. GLP-1s regulate lipid metabolism, reducing the effects of hyperlipidemia and helping to lower the risk for both chronic kidney disease (CKD) and diabetic kidney disease. They have also been shown to reduce oxidative stress, which includes stimulating glomerular filtration and reducing vasoconstriction, slowing the progression of CKD. Limited data from clinical trials have been published on the effects of GLP-1 receptor agonists in individuals with post-liver transplant diabetes mellitus (PTDM)

11 Semaglutide is FDA-approved for weight management in people with a body mass index of 30 or higher or 27 or higher with at least one weight-related condition such as high blood pressure or high cholesterol

Have You Noticed This Too